Tobacco Legislation Tobacco Regulation Euthanasia Policy Nutrition Policy Education Policy Drug Policy NHS Funding Youth Legislation Pandemic Response Vaccine Mandates Structural Reforms Government Accountability Preventive Strategies International Health Standards Drug Safety Policy Ayurveda Promotion Criminal Justice Reform Crisis Management Drug Regulation Policy Demographic Policy Social Policy Food Policy Epidemiology Substance Regulation Mental Health Policy Research Funding Policy Regulatory Oversight Vaping Legislation Environmental Policy Social Security Prison Policy Workplace Regulations Tobacco Control Policy Drug Regulation Agricultural Policy Public Health Issues Cannabis Policy Youth Protection Infrastructure Development Tobacco Policy Public Health Initiatives Drug Legislation Substance Abuse Policy Government Response Government Proposals Abortion Regulation
The agency says the move will target concentrated and lab‑made 7‑hydroxymitragynine products because regulators link them to rising poisonings and local overdose deaths.
